Phase II trial of vinfluinine and capecitabine in previously treated metastatic breast cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2016
At a glance
- Drugs Capecitabine (Primary) ; Vinflunine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 02 Dec 2016 Status changed from completed to withdrawn prior to enrolment.
- 02 Feb 2009 Status changed from not yet recruiting to completed, as reported by ClinicalTrials.gov.
- 28 May 2007 New trial record.